Bradford T. Whitmore - 07 Feb 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
10%+ Owner
Signature
Bradford T. Whitmore
Issuer symbol
CLSD
Transactions as of
07 Feb 2024
Net transactions value
+$599,999
Form type
4
Filing time
09 Feb 2024, 13:00:08 UTC
Previous filing
08 Dec 2023
Next filing
12 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $599,999 +444,444 +11% $1.35 4,495,034 07 Feb 2024 Direct
holding CLSD Common Stock 2,350,152 07 Feb 2024 by Grace Brothers, LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Warrant Purchase $0 +444,444 $0.000000 444,444 07 Feb 2024 Common Stock 444,444 $1.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bradford T. Whitmore is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock.